Welcome to our dedicated page for Imperva news (Ticker: IMPV), a resource for investors and traders seeking the latest updates and insights on Imperva stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Imperva's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Imperva's position in the market.
Novidea has appointed Eran Ben Ezer as its new Chief Financial Officer (CFO) to enhance its leadership team for the next phase of global growth. With 20 years of experience, Ben Ezer previously served at Drivenets, overseeing financing rounds totaling over
Scale Asia Ventures has launched a $30 million early-stage fund to support enterprise-focused startups, particularly those founded by expatriates with distributed teams. The fund aims to further provide up to $100 million in later-stage funding through its extensive Limited Partner network, which includes institutional funds and publicly traded corporations from the U.S., South Korea, Japan, and Singapore. The venture capital firm emphasizes its commitment to leveraging U.S. and Asian market expertise and global corporate partnerships to guide startups from inception to IPO.
